Summarized by Daily Strand AI from peer-reviewed source
For years, doctors relied on a medical formula that unintentionally made it harder for Black patients to receive kidney transplants. Medical professionals use a tool called the estimated glomerular filtration rate, or eGFR, to measure how well a person's kidneys are functioning. Until recently, this algorithm automatically inflated the scores for Black patients by 16% to 21%.
While higher scores might sound positive, they actually worked against these patients. The artificially inflated numbers made it look like their kidneys were much healthier than they truly were. This hidden severity masked serious kidney disease and ultimately delayed urgently needed organ transplants.
The medical community has since taken steps to correct this wrong. After phasing out the biased equation, the Organ Procurement and Transplantation Network required transplant programs to adjust the waitlist status for affected Black patients. By removing race from the algorithm, doctors have improved transplant access for Black patients. Researchers note one limitation in the current data is that the exact numerical increase in transplant access and the specific sample sizes of the affected population are not yet detailed.
This shift represents a crucial step forward in removing systemic biases from everyday medical decisions. Because the old equation artificially inflated kidney function estimates by up to 21%, many Black patients were unfairly pushed further down the transplant waitlist. Correcting this calculation means these individuals finally have a fair chance to be evaluated based on their true medical needs rather than a flawed mathematical assumption.
Furthermore, the official mandate ensures that this is an active correction rather than just a theoretical fix. By requiring programs to modify the status of affected patients already waiting for a transplant, the medical system is actively working to undo past harms. This policy change sets a vital precedent for how the medical industry can identify and fix biased clinical algorithms in the future to ensure fair treatment for everyone.
Interested in Diagnostics?
Newsletter
Never miss a breakthrough.
Join 10,000+ curious minds getting biotech stories distilled into plain language. Free, three times a week.